Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Activating cannabinoid receptor 1 may help manage psoriasis by reducing certain keratins.

NBCCS and BFHS might be the same syndrome, helping better identify and manage cases.

Prednisone treatment helped a woman with Cronkhite-Canada syndrome recover from hair loss and digestive issues.

Corneodesmosin is essential for skin and hair health, and its dysfunction can lead to skin and hair disorders.

Increasing calcium sensing receptor speeds up skin and hair development in mice.

CCCA in women of African ancestry may be caused by PADI3 gene mutations and intense hair grooming.

Patients with central centrifugal cicatricial alopecia may have a higher risk of breast and colorectal cancer.

Post-COVID syndrome symptoms are common and overlap with general health issues.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Flexible bioelectronics show promise in non-invasive cancer detection and treatment but need improvements in stability and effectiveness.

Far-infrared radiation improves stem cell growth and movement, helping heart therapy.

The engineered yeast strain BLYAS can quickly and sensitively detect androgenic chemicals.

The optimized Cinchonine gel effectively fights acne bacteria and is safe for twice-daily use.

Enhancing cannabinoid signaling may help treat skin inflammation.

Enteral supplements can improve symptoms of Cronkhite-Canada syndrome.

The report described a unique case of Cronkhite-Canada syndrome with unusual polyps and an association with multiple myeloma.

Betulinic acid can help treat hepatitis C by stopping virus replication.

Dr. Connelly agrees that linear basal cell carcinomas might be more aggressive but highlights the study's lack of clear criteria to identify them.

Cepharanthine may help treat COVID-19 by targeting multiple pathways.

The extracellular matrix affects where tumors can start in the body.

The study found that the quality of cord blood units remains consistent before freezing and after thawing, indicating that attached tube segments reliably represent the graft's properties.

A 60-year-old man with Cronkhite-Canada syndrome improved with treatment, but the condition has a high mortality rate and a risk of colorectal cancer.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Corticosteroids improved symptoms in a man with Cronkhite-Canada Syndrome.

CaBP1 and CaBP2 are important for continuous hearing by preventing inactivation of calcium currents in ear cells, with CaBP2 also able to restore hearing when reintroduced.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

Elderly patients with CCCA were all African American with low vitamin D, but no iron or zinc deficiencies, and no hormonal imbalances compared to younger patients.